Arkadiusz Weglewski
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 13, 2026
A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis.
Journal: European journal of neurology
Published: March 26, 2025
Iron deficiency anemia as a risk factor associated with stroke and cerebral venous thrombosis in children and adults - a systematic review.
Journal: Thrombosis research
Published: March 19, 2025
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 05, 2024
Patterns and predictors of multiple sclerosis phenotype transition.
Journal: Brain communications
Published: June 27, 2024
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 21, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.
Journal: JAMA neurology
Published: June 12, 2023
Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report.
Journal: Bulletin of the National Research Centre
Published: November 24, 2022
Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
Journal: PloS one
Published: December 01, 2020
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Journal: Neurology
Published: October 20, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026